Severe Steroid-responsive Skin Disorders Related to Ledipasvir and Sofosbuvir for HCV

Combination therapy with ledipasvir and sofosbuvir (LDV/SOF), direct-acting antiviral agents, is highly effective against hepatitis C virus genotype 1 infection. Although LDV/SOF is safer than conventional treatment, reports have indicated that LDV/SOF was discontinued in certain cases due to severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tadokoro, Tomoko, Morishita, Asahiro, Fujita, Koji, Oura, Kyoko, Sakamoto, Teppei, Nomura, Takako, Tani, Joji, Yoneyama, Hirohito, Masaki, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938499/
https://www.ncbi.nlm.nih.gov/pubmed/29279506
http://dx.doi.org/10.2169/internalmedicine.9744-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938499/
https://www.ncbi.nlm.nih.gov/pubmed/29279506
http://dx.doi.org/10.2169/internalmedicine.9744-17

Ejemplares similares